<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32815196</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4547</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of neuroscience research</Title><ISOAbbreviation>J Neurosci Res</ISOAbbreviation></Journal><ArticleTitle>Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2435</StartPage><EndPage>2450</EndPage><MedlinePgn>2435-2450</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jnr.24714</ELocationID><Abstract><AbstractText>There is currently no therapy impacting the course of amyotrophic lateral sclerosis (ALS). The only approved treatments are riluzole and edaravone, but their efficacy is modest and short-lasting, highlighting the need for innovative therapies. We previously demonstrated the ability of PXT864, a combination of low doses of acamprosate and baclofen, to synergistically restore cellular and behavioral activity in Alzheimer's and Parkinson's disease models. The overlapping genetic, molecular, and cellular characteristics of these neurodegenerative diseases supported investigating the effectiveness of PXT864 in ALS. As neuromuscular junction (NMJ) alterations is a key feature of ALS, the effects of PXT864 in primary neuron-muscle cocultures injured by glutamate were studied. PXT864 significantly and synergistically preserved NMJ and motoneuron integrity following glutamate excitotoxicity. PXT864 added to riluzole significantly improved such protection. PXT864 activity was then assessed in primary cultures of motoneurons derived from SOD1<sup>G93A</sup> rat embryos. These motoneurons presented severe maturation defects that were significantly improved by PXT864. In this model, glutamate application induced an accumulation of TDP-43 protein in the cytoplasm, a hallmark that was completely prevented by PXT864. The anti-TDP-43 aggregation effect was also confirmed in a cell line expressing TDP-43 fused to GFP. These results demonstrate the value of PXT864 as a promising therapeutic strategy for the treatment of ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Journal of Neuroscience Research published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boussicault</LastName><ForeName>Lydie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6038-2547</Identifier><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffaire</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaudo</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callizot</LastName><ForeName>No&#xeb;lle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>NEUROSYS SAS, Gardanne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabirotchkin</LastName><ForeName>Serguei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajj</LastName><ForeName>Rodolphe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>PHARNEXT, Paris, 75009, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci Res</MedlineTA><NlmUniqueID>7600111</NlmUniqueID><ISSNLinking>0360-4012</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058786">GABA-B Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>H789N3FKE8</RegistryNumber><NameOfSubstance UI="D001418">Baclofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>N4K14YGM3J</RegistryNumber><NameOfSubstance UI="D000077443">Acamprosate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077443" MajorTopicYN="N">Acamprosate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001418" MajorTopicYN="N">Baclofen</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058786" MajorTopicYN="N">GABA-B Receptor Agonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RRID:AB_143157</Keyword><Keyword MajorTopicYN="N">RRID:AB_2271509</Keyword><Keyword MajorTopicYN="N">RRID:AB_2633275</Keyword><Keyword MajorTopicYN="N">RRID:AB_477193</Keyword><Keyword MajorTopicYN="N">RRID:AB_477257</Keyword><Keyword MajorTopicYN="N">RRID:AB_477272</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neuroprotection</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>All the authors except No&#xeb;lle Callizot are employee of Pharnext. RH, SN, and DC are cited in patents held by Pharnext. The authors declare this study was founded by Pharnext. The funder had the following involvement with the study: study design, data collection and analysis, decision to publish and preparation of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32815196</ArticleId><ArticleId IdType="pmc">PMC7693228</ArticleId><ArticleId IdType="doi">10.1002/jnr.24714</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Attarian, S. , Vallat, J. M. , Magy, L. , Funalot, B. , Gonnaud, P.&#x2010;M. , Lacour, A. , &#x2026; Cohen, D. (2014). An exploratory randomised double&#x2010;blind and placebo&#x2010;controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot&#x2010;Marie&#x2010;Tooth disease type 1A. Orphanet Journal of Rare Diseases, 9, 1&#x2013;15. 10.1186/s13023-014-0199-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-014-0199-0</ArticleId><ArticleId IdType="pmc">PMC4311411</ArticleId><ArticleId IdType="pubmed">25519680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala, V. , Granado&#x2010;Serrano, A. B. , Cacabelos, D. , Naud&#xed;, A. , Ilieva, E. V. , Boada, J. , &#x2026; Portero&#x2010;Otin, M. (2011). Cell stress induces TDP&#x2010;43 pathological changes associated with ERK1/2 dysfunction: Implications in ALS. Acta Neuropathologica, 122, 259&#x2013;270. 10.1007/s00401-011-0850-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0850-y</ArticleId><ArticleId IdType="pubmed">21706176</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia, G. , &amp; Bruno, V. (2018). Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: New potential drug targets for therapeutic applications. Current Opinion in Pharmacology, 38, 65&#x2013;71. 10.1016/j.coph.2018.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.02.007</ArticleId><ArticleId IdType="pubmed">29529498</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning, B. A. , &amp; Walker, A. K. (2019). The pathobiology of TDP&#x2010;43 C&#x2010;terminal fragments in ALS and FTLD. Frontiers in Neuroscience, 13, 1&#x2013;27. 10.3389/fnins.2019.00335</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland, L. G. , Nirmalananthan, N. , Yip, J. , Greensmith, L. , &amp; Duchen, M. R. (2008). Expression of mutant SOD1G93Ain astrocytes induces functional deficits in motoneuron mitochondria. Journal of Neurochemistry, 107, 1271&#x2013;1283. 10.1111/j.1471-4159.2008.05699.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05699.x</ArticleId><ArticleId IdType="pubmed">18808448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco, D. A. , Morfini, G. , Karabacak, N. M. , Song, Y. , Gros&#x2010;Louis, F. , Pasinelli, P. , &#x2026; Brown, R. H. (2010). Wild&#x2010;type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nature Neuroscience, 13, 1396&#x2013;1403. 10.1038/nn.2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira, M. V. , Curcio, M. , Leal, G. , Salazar, I. L. , Mele, M. , Santos, A. R. A. , &#x2026; Duarte, C. B. (2013). Excitotoxic stimulation downregulates the ubiquitin&#x2010;proteasome system through activation of NMDA receptors in cultured hippocampal neurons. Biochimica Et Biophysica Acta (BBA)&#x2014;Molecular Basis of Disease, 1832, 263&#x2013;274. 10.1016/j.bbadis.2012.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2012.10.009</ArticleId><ArticleId IdType="pubmed">23069389</ArticleId></ArticleIdList></Reference><Reference><Citation>Callizot, N. , Combes, M. , Steinschneider, R. , &amp; Poindron, P. (2013). Operational dissection of &#x3b2;&#x2010;amyloid cytopathic effects on cultured neurons. Journal of Neuroscience Research, 91, 706&#x2013;716. 10.1002/jnr.23193</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23193</ArticleId><ArticleId IdType="pubmed">23404368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, Q. , &amp; Martin, L. J. (2011). Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience, 31, 2815&#x2013;2827. 10.1523/JNEUROSCI.2475-10.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2475-10.2011</ArticleId><ArticleId IdType="pmc">PMC3081715</ArticleId><ArticleId IdType="pubmed">21414903</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheah, B. , Vucic, S. , Krishnan, A. , &amp; Kiernan, M. (2010). Riluzole, neuroprotection and amyotrophic lateral sclerosis. Current Medicinal Chemistry, 17(18), 1942&#x2013;1959. 10.2174/092986710791163939</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986710791163939</ArticleId><ArticleId IdType="pubmed">20377511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov, I. , Milet, A. , Cholet, N. , Primas, G. , Boucard, A. , Pereira, Y. , &#x2026; Cohen, D. (2014). Polytherapy with a combination of three repurposed drugs (PXT3003) down&#x2010;regulates Pmp22 over&#x2010;expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases, 9, 1&#x2013;16. 10.1186/s13023-014-0201-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-014-0201-x</ArticleId><ArticleId IdType="pmc">PMC4279797</ArticleId><ArticleId IdType="pubmed">25491744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov, I. , Nabirotchkin, S. , Cholet, N. , Milet, A. , Boucard, A. , Toulorge, D. , &#x2026; Cohen, D. (2015). Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy. Scientific Reports, 5, 1&#x2013;12. 10.1038/srep07608</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep07608</ArticleId><ArticleId IdType="pmc">PMC5378993</ArticleId><ArticleId IdType="pubmed">25566747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli, E. T. , Lasseigne, B. N. , Petrovski, S. , Sapp, P. C. , Dion, P. A. , Leblond, C. S. , &#x2026; Goldstein, D. B. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science, 347, 1436 10.1126/science.aaa3650</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes, M. , Poindron, P. , &amp; Callizot, N. (2015). Glutamate protects neuromuscular junctions from deleterious effects of &#x3b2;&#x2010;amyloid peptide and conversely: An in vitro study in a nerve&#x2010;muscle coculture. Journal of Neuroscience Research, 93(4), 633&#x2013;643. 10.1002/jnr.23524</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23524</ArticleId><ArticleId IdType="pubmed">25491262</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa, V. , Cicardi, M. E. , Ramesh, N. , Seguin, S. J. , Ganassi, M. , Bigi, I. , &#x2026; Carra, S. (2016). The chaperone HSPB8 reduces the accumulation of truncated TDP&#x2010;43 species in cells and protects against TDP&#x2010;43&#x2010;mediated toxicity. Human Molecular Genetics, 25, 3908&#x2013;3924. 10.1093/hmg/ddw232</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw232</ArticleId><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon&#x2010;Nachum, M. , Melamed, E. , &amp; Offen, D. (2011). The &#x201c;dying&#x2010;back&#x201d; phenomenon of motor neurons in ALS. Journal of Molecular Neuroscience, 43, 470&#x2013;477. 10.1007/s12031-010-9467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahchour, A. , De Witte, P. , Bolo, N. , N&#xe9;d&#xe9;lec, J.&#x2010;F. , Muzet, M. , Durbin, P. , &amp; Macher, J.&#x2010;P. (1998). Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Research, 82(2), 107&#x2013;114. 10.1016/S0925-4927(98)00016-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4927(98)00016-X</ArticleId><ArticleId IdType="pubmed">9754453</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho, M. , Eisen, A. , Krieger, C. , &amp; Swash, M. (2014). Motoneuron firing in amyotrophic lateral sclerosis (ALS). Frontiers in Human Neuroscience, 8, 1&#x2013;14. 10.3389/fnhum.2014.00719</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2014.00719</ArticleId><ArticleId IdType="pmc">PMC4170108</ArticleId><ArticleId IdType="pubmed">25294995</ArticleId></ArticleIdList></Reference><Reference><Citation>Djakovic, S. N. , Schwarz, L. A. , Barylko, B. , DeMartino, G. N. , &amp; Patrick, G. N. (2009). Regulation of the proteasome by neuronal activity and calcium/calmodulin&#x2010;dependent protein kinase II. Journal of Biological Chemistry, 284, 26655&#x2013;26665. 10.1074/jbc.M109.021956</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.021956</ArticleId><ArticleId IdType="pmc">PMC2785353</ArticleId><ArticleId IdType="pubmed">19638347</ArticleId></ArticleIdList></Reference><Reference><Citation>Do&#x2010;Ha, D. , Buskila, Y. , &amp; Ooi, L. (2018). Impairments in motor neurons, interneurons and astrocytes contribute to hyperexcitability in ALS: Underlying mechanisms and paths to therapy. Molecular Neurobiology, 55, 1410&#x2013;1418. 10.1007/s12035-017-0392-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0392-y</ArticleId><ArticleId IdType="pubmed">28160214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, T. , Al Khleifat, A. , Meurgey, J. H. , Jones, A. , Leigh, P. N. , Bensimon, G. , &amp; Al&#x2010;Chalabi, A. (2018). Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: A retrospective analysis of data from a dose&#x2010;ranging study. Lancet Neurology, 17, 416&#x2013;422. 10.1016/S1474-4422(18)30054-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, L. R. , Culver, D. G. , Tennant, P. , Davis, A. A. , Wang, M. , Castellano&#x2010;Sanchez, A. , &#x2026; Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185, 232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Foucquier, J. , &amp; Guedj, M. (2015). Analysis of drug combinations: Current methodological landscape. Pharmacology Research &amp; Perspectives, 3, e00149 10.1002/prp2.149</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.149</ArticleId><ArticleId IdType="pmc">PMC4492765</ArticleId><ArticleId IdType="pubmed">26171228</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, P. , Wu, Q. , Hu, J. , Li, T. , &amp; Gao, F. (2016). Baclofen protects primary rat retinal ganglion cells from chemical hypoxia&#x2010;induced apoptosis through the Akt and PERK pathways. Frontiers in Cellular Neuroscience, 10, 1&#x2013;14. 10.3389/fncel.2016.00255</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00255</ArticleId><ArticleId IdType="pmc">PMC5095369</ArticleId><ArticleId IdType="pubmed">27867349</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannetti, E. , &amp; Fuhrmann, M. (2019). Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease. Brain Research, 1707, 216&#x2013;226. 10.1016/j.brainres.2018.11.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.11.042</ArticleId><ArticleId IdType="pubmed">30503351</ArticleId></ArticleIdList></Reference><Reference><Citation>Group, WGE (MCI&#x2010;186) A 19 S . (2017). Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double&#x2010;blind, placebo&#x2010;controlled trial. Lancet Neurology.16(7), 505&#x2013;512. 10.1016/S1474-4422(17)30115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney, M. , Pu, H. , Chiu, A. , Dal Canto, M. C. , Polchow, D. Y. , Alexander, D. D. , , &#x2026; Deng, H. X. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264(5166), 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajj, R. , Milet, A. , Toulorge, D. , Cholet, N. , Laffaire, J. , Foucquier, J. , &#x2026; Cohen, D. (2015). Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease. Scientific Reports, 5, 1&#x2013;13. 10.1038/srep16084</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16084</ArticleId><ArticleId IdType="pmc">PMC4635348</ArticleId><ArticleId IdType="pubmed">26542636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg, M. C. , Halang, L. , Woods, I. , Coughlan, K. S. , &amp; Prehn, J. H. M. (2017). Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(5&#x2010;6), 438&#x2013;445. 10.1080/21678421.2017.1407796</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407796</ArticleId><ArticleId IdType="pubmed">29221425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince, P. , Stout, N. , Shaw, P. , Slade, J. , Hunziker, W. , Heizmann, C. W. , &amp; Baimbridge, K. G. (1993). Parvalbumin and calbindin D&#x2010;28k in the human motor system and in motor neuron disease. Neuropathology and Applied Neurobiology, 19, 291&#x2013;299. 10.1111/j.1365-2990.1993.tb00443.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00443.x</ArticleId><ArticleId IdType="pubmed">8232749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas, P. , Bischofberger, J. , &amp; Sandk&#xfc;hler, J. (1998). Corelease of two fast neurotransmitters at a central synapse. Science, 281, 419&#x2013;424. 10.1126/science.281.5375.419</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5375.419</ArticleId><ArticleId IdType="pubmed">9665886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan, M. C. , Ziemann, U. , &amp; Eisen, A. (2019). Amyotrophic lateral sclerosis: Origins trace to impaired balance between neural excitation and inhibition in the neonatal period. Muscle and Nerve, 60(3), 232&#x2013;235. 10.1002/mus.26617</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26617</ArticleId><ArticleId IdType="pubmed">31233613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J. K. , Kim, Y. S. , Lee, H. M. , Jin, H. S. , Neupane, C. , Kim, S. , &#x2026; Jo, E.&#x2010;K. (2018). GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nature Communications, 9(1), 1&#x2013;17. 10.1038/s41467-018-06487-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06487-5</ArticleId><ArticleId IdType="pmc">PMC6180030</ArticleId><ArticleId IdType="pubmed">30305619</ArticleId></ArticleIdList></Reference><Reference><Citation>King, A. E. , Woodhouse, A. , Kirkcaldie, M. T. K. , &amp; Vickers, J. C. (2016). Excitotoxicity in ALS: Overstimulation, or overreaction? Experimental Neurology, 275, 162&#x2013;171. 10.1016/j.expneurol.2015.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez, L. , Bensimon, G. , Leigh, P. N. , Guillet, P. , &amp; Meininger, V. (1996). Dose&#x2010;ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet, 347, 1425&#x2013;1431. 10.5555/URI:PII:S0140673696916803</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/URI:PII:S0140673696916803</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, J. , &amp; Yue, Z. (2015). Neuronal aggregates: Formation, clearance, and spreading. Developmental Cell, 32, 491&#x2013;501. 10.1016/j.devcel.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2015.02.002</ArticleId><ArticleId IdType="pmc">PMC4376477</ArticleId><ArticleId IdType="pubmed">25710535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, L. , Li, C. , Lu, Y. , Zong, X. , Luo, C. , Sun, J. , &amp; Guo, L. (2015). Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion. Scientific Reports, 5(1), 1&#x2013;17. 10.1038/srep14474</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14474</ArticleId><ArticleId IdType="pmc">PMC4585985</ArticleId><ArticleId IdType="pubmed">26412641</ArticleId></ArticleIdList></Reference><Reference><Citation>Malessa, S. , Leigh, P. N. , Bertel, O. , Sluga, E. , &amp; Hornykiewicz, O. (1991). Amyotrophic lateral sclerosis: Glutamate dehydrogenase and transmitter amino acids in the spinal cord. Journal of Neurology, Neurosurgery and Psychiatry, 54, 984&#x2013;988. 10.1136/jnnp.54.11.984</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.54.11.984</ArticleId><ArticleId IdType="pmc">PMC1014621</ArticleId><ArticleId IdType="pubmed">1686899</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinou, J. C. , Martinou, I. , &amp; Kato, A. C. (1992). Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro. Neuron, 8, 737&#x2013;744. 10.1016/0896-6273(92)90094-T</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90094-T</ArticleId><ArticleId IdType="pubmed">1567622</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas, D. B. , Valenzuela, V. , &amp; Hetz, C. (2018). Proteostasis disturbance in amyotrophic lateral sclerosis. Human Molecular Genetics, 26, 91&#x2013;104. 10.1093/hmg/ddx274</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx274</ArticleId><ArticleId IdType="pubmed">28977445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehring, R. B. , Horikawa, H. P. M. , El, F. O. , Kneussel, M. , Brandst&#xe4;tter, J. H. , Stamm, S. , &#x2026; Karschin, A. (2000). The metabotropic GABA b receptor directly interacts with the activating transcription factor 4. Journal of Biological Chemistry, 275, 35185&#x2013;35191. 10.1074/jbc.M002727200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002727200</ArticleId><ArticleId IdType="pubmed">10924501</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M. , Sampathu, D. , Kwong, L. , Truax, A. C. , Micsenyi, M. C. , Chou, T. T. , &#x2026; Lee, V.&#x2010; M.&#x2010;Y. (2006). Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez&#x2010;Jarqu&#xed;n, U. N. , &amp; Tapia, R. (2018). Excitatory and inhibitory neuronal circuits in the spinal cord and their role in the control of motor neuron function and degeneration. ACS Chemical Neuroscience, 9, 211&#x2013;216. 10.1021/acschemneuro.7b00503</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00503</ArticleId><ArticleId IdType="pubmed">29350907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha, M. C. , Pousinha, P. A. , Correia, A. M. , Sebasti&#xe3;o, A. M. , &amp; Ribeiro, J. A. (2013). Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One, 8, 1&#x2013;11. 10.1371/journal.pone.0073846</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D. R. , Siddique, T. , Patterson, D. , Figlewicz, D. A. , Sapp, P. , Hentati, A. , &#x2026; Brown, R. H. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjari Moghaddam, H. , Zare&#x2010;Shahabadi, A. , Rahmani, F. , &amp; Rezaei, N. (2017). Neurotransmission systems in Parkinson's disease. Reviews in the Neurosciences, 28, 509&#x2013;536. 10.1515/revneuro-2016-0068</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2016-0068</ArticleId><ArticleId IdType="pubmed">28328536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter, K. , Grampp, T. , Fritschy, J. , Kaupmann, K. , Bettler, B. , Mohler, H. , &amp; Benke, D. (2005). Subtype&#x2010;selective interaction with the transcription factor CCAAT / enhancer&#x2010;binding protein (C / EBP) homologous protein (CHOP) regulates cell surface expression of GABA B receptors. Journal of Biological Chemistry, 280, 33566&#x2013;33572. 10.1074/jbc.M503482200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M503482200</ArticleId><ArticleId IdType="pubmed">16081421</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena, S. , Cabuy, E. , &amp; Caroni, P. (2009). A role for motoneuron subtype&#x2010;selective ER stress in disease manifestations of FALS mice. Nature Neuroscience, 12, 627&#x2013;636. 10.1038/nn.2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijffers, R. , Zhang, J. , Matthews, J. C. , Chen, A. , Tamrazian, E. , Babaniyi, O. , &#x2026; Brown, R. H. (2014). ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proceedings of the National Academy of Sciences, 111, 1622&#x2013;1627. 10.1073/pnas.1314826111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314826111</ArticleId><ArticleId IdType="pmc">PMC3910594</ArticleId><ArticleId IdType="pubmed">24474789</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens, B. , Guiloff, R. J. , Navarrete, R. , Newman, P. , Nikhar, N. , &amp; Lewis, P. (2006). Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. Journal of the Neurological Sciences, 244, 41&#x2013;58. 10.1016/j.jns.2005.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.12.003</ArticleId><ArticleId IdType="pubmed">16487542</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, J. P. , Brown, R. H. , &amp; Cleveland, D. W. (2016). Decoding ALS: From genes to mechanism. Nature, 539, 197&#x2013;206. 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W. , Li, L. , Lin, W. L. , Dickson, D. W. , Petrucelli, L. , Zhang, T. , &amp; Wang, X. (2013). The ALS disease&#x2010;associated mutant TDP&#x2010;43 impairs mitochondrial dynamics and function in motor neurons. Human Molecular Genetics, 22, 4706&#x2013;4719. 10.1093/hmg/ddt319</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap, Y. W. , Llanos, R. M. , La Fontaine, S. , Cater, M. A. , Beart, P. M. , &amp; Cheung, N. S. (2016). Comparative microarray analysis identifies commonalities in neuronal injury: Evidence for oxidative stress, dysfunction of calcium signalling, and inhibition of autophagy&#x2010;lysosomal pathway. Neurochemical Research, 41, 554&#x2013;567. 10.1007/s11064-015-1666-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1666-2</ArticleId><ArticleId IdType="pubmed">26318862</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon, Y. K. , Lee, K. C. , Cho, H. E. , Chae, M. , Chang, J. W. , Chang, W. S. , &amp; Cho, S.&#x2010;R. (2017). Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Medicine, 34, e7472 10.1097/MD.0000000000007472</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007472</ArticleId><ArticleId IdType="pmc">PMC5571990</ArticleId><ArticleId IdType="pubmed">28834868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette, G. , Tamburin, S. , Manganotti, P. , Refatti, N. , Forgione, A. , &amp; Rizzuto, N. (2002a). Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clinical Neurophysiology, 113, 1688&#x2013;1697. 10.1016/S1388-2457(02)00288-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(02)00288-2</ArticleId><ArticleId IdType="pubmed">12417221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette, G. , Tamburin, S. , Manganotti, P. , Refatti, N. , Forgione, A. , &amp; Rizzuto, N. (2002b). Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. Journal of Neurology, 249, 1723&#x2013;1728. 10.1007/s00415-002-0926-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-002-0926-7</ArticleId><ArticleId IdType="pubmed">12529797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>